Product Overview
IGF LR3 is a synthetic analogue of insulin-like growth factor-1 (IGF-1), modified with an extended amino acid sequence to support increased stability and prolonged activity in controlled laboratory environments.
It is commonly investigated in preclinical research models examining cellular signalling pathways, growth factor interactions, receptor binding activity, and peptide-mediated biological processes under controlled experimental conditions.
Due to its structural modifications and receptor interaction profile, IGF LR3 has become a continued subject of interest in research relating to cellular response mechanisms, peptide signalling behaviour, and metabolic pathway activity.
Supplied in lyophilised form, each vial is prepared to support precision handling, stability, and reproducibility within laboratory settings.
Verification Standard
Every batch of IGF LR3 supplied by Peptology Labs undergoes a controlled, batch-specific verification process:
- High-Performance Liquid Chromatography (HPLC) purity analysis
- Mass spectrometry (LC-MS) identity confirmation
- Independently tested by a third-party analytical laboratory
- Additional verification through internationally recognised analytical partners such as Janoshik Analytical
Batch-specific Certificates of Analysis (COAs) are provided for full transparency and traceability.
Product Specification
- Quantity: 1mg per vial
- Form: Lyophilised powder
- Purity: ≥99% (HPLC)
- Verification: Independently tested (batch specific)
- Storage: Store refrigerated in a dry environment
- Intended Use: Research use only. Not for human or veterinary use.
